
STAAR Surgical Company: updates and filings
Price
$25.40
November 18, 2026Market cap $1.3B
What Ploutos Investor adds for STAAR Surgical
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from FY2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 4, 2026next Feb 17, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
August 2026
June 2026
May 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 4, 2026Quarterly reportfor the period to Oct 2, 2026Form10-Q
- Nov 4, 2026Results of operations, Regulation FD disclosureForm8-K
- Oct 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Oct 5, 2026Officer or director change, Regulation FD disclosure (amendment)Form8-K/A
- Sep 10, 2026Officer or director change, Regulation FD disclosureForm8-K
- Aug 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 12, 2026Quarterly reportfor the period to Jul 3, 2026Form10-Q
- Aug 12, 2026Results of operations, Regulation FD disclosureForm8-K
- Aug 6, 2026Officer or director change, Regulation FD disclosureForm8-K
- Jun 24, 2026Shares registered for employeesFormS-8
- Jun 22, 2026Officer or director change, shareholder voteForm8-K
- Jun 9, 2026Officer or director changeForm8-K
- May 13, 2026Quarterly reportfor the period to Apr 3, 2026Form10-Q
- May 13, 2026Results of operations, Regulation FD disclosureForm8-K
- May 12, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- May 4, 2026Annual report to shareholdersfor the period to Jan 2, 2026FormARS
- May 4, 2026Additional annual meeting materialFormDEFA14A
- May 4, 2026Annual meeting proxy statementFormDEF 14A
- Apr 24, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Apr 20, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 8, 2026Regulation FD disclosureForm8-K
- Mar 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 13, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 4, 2026 | 10-Q | Quarterly reportfor the period to Oct 2, 2026 | Document |
| Nov 4, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Oct 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Oct 5, 2026 | 8-K/A | Officer or director change, Regulation FD disclosure (amendment) | Document |
| Sep 10, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Aug 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 12, 2026 | 10-Q | Quarterly reportfor the period to Jul 3, 2026 | Document |
| Aug 12, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Aug 6, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Jun 24, 2026 | S-8 | Shares registered for employees | Document |
| Jun 22, 2026 | 8-K | Officer or director change, shareholder vote | Document |
| Jun 9, 2026 | 8-K | Officer or director change | Document |
| May 13, 2026 | 10-Q | Quarterly reportfor the period to Apr 3, 2026 | Document |
| May 13, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| May 12, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| May 4, 2026 | ARS | Annual report to shareholdersfor the period to Jan 2, 2026 | Document |
| May 4, 2026 | DEFA14A | Additional annual meeting material | Document |
| May 4, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Apr 24, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Apr 20, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 8, 2026 | 8-K | Regulation FD disclosure | Document |
| Mar 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 13, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC since May 2, 1995: every report, 8-K, meeting and letter. Of its other filings (1,015 in all), the newest.
The full analysis
What do STAAR Surgical's filings show?
The filings are where every one of STAAR Surgical's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.